Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The metric has seen a significant gain of 132.61% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 125.26%. Over the past 30 days, the price of QNTM has fallen by 73.28%. And in the last five days, it has surged by 51.24%.
In terms of market performance, Quantum BioPharma Ltd had a somewhat inconsistent run in. The highest value for the stock in the past year was $46.87 on 04/02/24, while the lowest value was $2.70 on 12/20/24.
52-week price history of QNTM Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Quantum BioPharma Ltd’s current trading price is -81.73% away from its 52-week high, while its distance from the 52-week low is 217.04%. The stock’s price range for this period has been between $2.70 and $46.87. The Healthcare sector company’s shares saw a trading volume of about 14.08 million for the day, which was higher than the average daily volume of 2.6 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Quantum BioPharma Ltd (QNTM) has experienced a quarterly rise of 157.83% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 16.44M and boasts a workforce of 7 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.21, with a change in price of +3.83. Similarly, Quantum BioPharma Ltd recorded 1,758,240 in trading volume during the last 100 days, posting a change of +80.97%.
QNTM’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for QNTM stands at 0.07. Similarly, the long-term debt-to-equity ratio is also 0.00.
QNTM Stock Stochastic Average
As of today, the raw stochastic average of Quantum BioPharma Ltd over the past 50 days is 37.52%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 53.73%. Additionally, the Stochastic %K and %D values for the company were 67.89% and 58.93%, respectively, over the past 20 days.
